Stem Cell Transplantation: Basic/Clinical Research
干细胞移植:基础/临床研究
基本信息
- 批准号:7135148
- 负责人:
- 金额:$ 259.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
We propose to continue an integrated program of basic and clinical research to improve treatment of patients with acquired and inherited nonmalignant blood disorders and myelodysplastic syndromes by hematopoietic cell transplantation (HCT). The two clinical projects pursue two shared overall objectives for allogeneic HCT. One is to reduce conditioning-related toxicities and transplantation associated complications including graft rejection and graft-versus-host disease (GVHD). The other is to broaden the choice of hematopoietic cell donors beyond HLA-matched related and unrelated individuals by including grafts of HLA-haploidentical marrow cells and unrelated cord blood. The two preclinical projects will use a canine model with a long history of successful translation into clinical trials. One Project seeks to further improve major histocompatibility complex haploidentical HCT, in part by exploring combinations of biological and pharmacological immunosuppressive agents and in part by exploring novel post-transplantation chemotherapy strategies in combination with methods of transfer of drug resistance genes developed The other Project proposes to further optimize efficacy and safety of gene transfer into hematopoietic cells, test the therapeutic efficacy and safety of gene transfer in a clinically relevant canine inherited blood disorder, and study long-term consequences of gene transfer. The four research projects are supported by four core units, which provide study design, data processing, statistical analyses, protocol management, and coordination of multi-center trials, assessment of immune functions after transplantation, management of chronic GVHD,and long-term follow-up. The principles derived from the studies under this grant have had and will continue to have broad implications for marrow and blood stem cell transplantation and gene therapy in the treatment of patients with other malignant and nonmalignant blood disorders.
描述(由申请人提供):
我们建议继续进行基础和临床研究的综合计划,以改善造血细胞移植(HCT)对获得性和遗传性非恶性血液病和骨髓增生异常综合征患者的治疗。这两个临床项目追求同种异体HCT的两个共同的总体目标。一个是减少条件相关毒性和移植相关并发症,包括移植物排斥和移植物抗宿主病(GVHD)。另一个是扩大造血细胞供体的选择范围,包括HLA半相合骨髓细胞和无关脐带血的移植物,而不仅仅是HLA相合的相关和无关个体。这两个临床前项目将使用一种具有长期成功转化为临床试验历史的犬模型。其中一个项目旨在进一步改善主要组织相容性复合体单倍体相同的HCT,部分通过探索生物和药理学免疫抑制剂的组合,部分通过探索新型移植后化疗策略结合开发的耐药基因转移方法。另一个项目提出进一步优化基因转移到造血细胞的功效和安全性,测试基因转移在临床相关犬遗传性血液病中的治疗效果和安全性,并研究基因转移的长期后果。这四个研究项目由四个核心单位支持,提供研究设计,数据处理,统计分析,方案管理,多中心试验协调,移植后免疫功能评估,慢性GVHD管理和长期随访。从这项资助下的研究中得出的原则已经并将继续对骨髓和血液干细胞移植以及治疗其他恶性和非恶性血液疾病患者的基因治疗产生广泛的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rainer F. Storb其他文献
Response Endpoints for Acute Graft-Versus-Host Disease Treatment Trials
- DOI:
10.1016/j.bbmt.2012.11.494 - 发表时间:
2013-02-01 - 期刊:
- 影响因子:
- 作者:
Yoshihiro Inamoto;Paul J. Martin;Barry Storer;Marco Mielcarek;Rainer F. Storb;Paul A. Carpenter - 通讯作者:
Paul A. Carpenter
Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Myeloid Leukemia Older Than Age 60
- DOI:
10.1182/blood-2024-206221 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Phuong T Vo;Brenda M. Sandmaier;Megan Othus;Naveed Ali;Eduardo Rodríguez-Arbolí;Corentin Orvain;Chris Davis;Ryan S. Basom;Rainer F. Storb;Roland B. Walter - 通讯作者:
Roland B. Walter
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
- DOI:
10.1016/j.bbmt.2012.11.119 - 发表时间:
2013-02-01 - 期刊:
- 影响因子:
- 作者:
Lauri Burroughs;Eneida Nemecek;Troy Torgerson;Katherine A. Guthrie;Julie-An Talano;Jennifer Domm;Akiko Shimamura;Paul A. Carpenter;Suzanne Skoda-Smith;Janet A. Englund;K. Scott Baker;Rainer F. Storb;Ann Woolfrey - 通讯作者:
Ann Woolfrey
Radioimmunotherapy-Augmented Nonmyeloablative Allogeneic Transplantation Improves Outcomes for Refractory Indolent B-Cell Non-Hodgkin Lymphoma: Results of an Adjusted Cohort Analysis
- DOI:
10.1016/j.bbmt.2013.12.087 - 发表时间:
2014-02-01 - 期刊:
- 影响因子:
- 作者:
Ryan D. Cassaday;Barry E. Storer;Mohamed L. Sorror;Brenda M. Sandmaier;Katherine A. Guthrie;Lacey M. Hedin;Jennifer E. Roden;Joseph G. Rajendran;John M. Pagel;David G. Maloney;Rainer F. Storb;Oliver W. Press;Ajay K. Gopal - 通讯作者:
Ajay K. Gopal
BCMA-Directed Low Dose Alpha-Emitter Therapy Eliminates Minimal Residual Disease in a Multiple Myeloma Mouse Xenograft Model
- DOI:
10.1182/blood-2023-188055 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Melissa L Comstock;Shyril O'Steen;Yukang Lin;Donald Hamlin;D Scott Wilbur;Johnnie J. Orozco;Rainer F. Storb;Roland B. Walter;Pinar Ataca Atilla;Brian G Till;Geoffrey R Hill;Brenda M. Sandmaier;Damian J Green - 通讯作者:
Damian J Green
Rainer F. Storb的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rainer F. Storb', 18)}}的其他基金
Cell and Gene Therapy for Nonmalignant Blood Disorders
非恶性血液疾病的细胞和基因疗法
- 批准号:
8934992 - 财政年份:2015
- 资助金额:
$ 259.12万 - 项目类别:
Establishing Mixed Hematopoietic Chimerism in a Canine Model
在犬模型中建立混合造血嵌合状态
- 批准号:
8240003 - 财政年份:2011
- 资助金额:
$ 259.12万 - 项目类别:
Nonmyeloablative Hematopoietic Cell Allotransplants
非清髓性造血细胞同种异体移植
- 批准号:
8277817 - 财政年份:2011
- 资助金额:
$ 259.12万 - 项目类别:
Mixed Hematopoietic Chimerism After Stem Cell Allografts
干细胞同种异体移植后的混合造血嵌合
- 批准号:
8067936 - 财政年份:2009
- 资助金额:
$ 259.12万 - 项目类别:
Mixed Hematopoietic Chimerism After Stem Cell Allografts
干细胞同种异体移植后的混合造血嵌合
- 批准号:
7796833 - 财政年份:2009
- 资助金额:
$ 259.12万 - 项目类别:
Mixed Hematopoietic Chimerism After Stem Cell Allografts
干细胞同种异体移植后的混合造血嵌合
- 批准号:
8459330 - 财政年份:2009
- 资助金额:
$ 259.12万 - 项目类别:
Establishing Mixed Hematopoietic Chimerism in a Canine Model
在犬模型中建立混合造血嵌合状态
- 批准号:
7585354 - 财政年份:2009
- 资助金额:
$ 259.12万 - 项目类别:
Mixed Hematopoietic Chimerism After Stem Cell Allografts
干细胞同种异体移植后的混合造血嵌合
- 批准号:
7561146 - 财政年份:2009
- 资助金额:
$ 259.12万 - 项目类别:
相似海外基金
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
GPRASP family as novel regulators in hematopoietic stem cells
GPRASP 家族作为造血干细胞的新型调节因子
- 批准号:
10886980 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells
保护骨髓生态位的完整性和功能,使老化的造血干细胞恢复活力
- 批准号:
10735925 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
Elucidation of molecular mechanisms of immune cell differentiation of a novel Rab protein in hematopoietic stem cells
阐明造血干细胞中新型Rab蛋白免疫细胞分化的分子机制
- 批准号:
23K16122 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of methods for inducing hematopoietic stem cells
造血干细胞诱导方法的开发
- 批准号:
23K18305 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Self-Assembling Peptide Nanoparticles for in vivo Genome Editor Delivery to Hematopoietic Stem Cells
用于体内基因组编辑器递送至造血干细胞的自组装肽纳米颗粒
- 批准号:
10605021 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
The differentiation fate determination of hematopoietic stem cells involved in disease pathogenesis
造血干细胞分化命运决定参与疾病发病机制
- 批准号:
23K18287 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Identifying the role of MLKL in hematopoietic stem cells and leukemic stem cells
鉴定 MLKL 在造血干细胞和白血病干细胞中的作用
- 批准号:
23KJ0451 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Elucidation of the mechanism of maintaining hematopoietic stem cells by newly identified bone marrow mesenchymal stem cells.
阐明新鉴定的骨髓间充质干细胞维持造血干细胞的机制。
- 批准号:
23H02935 - 财政年份:2023
- 资助金额:
$ 259.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)